AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31844684 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight reduction followed by IVF treatment
Number of subjects: 305
Study 31844684 — intervention group
Group type: COMPARATOR
Intervention: IVF treatment-only
Number of subjects: 305
Study 31845007 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth perioperative physical activity intervention (4 sessions with PT/OT before surgery and up to 2 weeks post-discharge)
Number of subjects: 34
Study 31845007 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth perioperative physical activity intervention
Number of subjects: 34
Study 31845213 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening and management tool for geriatric syndromes
Number of subjects: 429
Study 31845423 — intervention group
Group type: COMPARATOR
Intervention: Higher leptin concentrations in children with overweight/obesity compared to normal weight children
Number of subjects: 2258
Study 31845423 — intervention group
Group type: COMPARATOR
Intervention: Lower adiponectin concentrations in children with overweight/obesity compared to normal weight children
Number of subjects: 2258
Study 31845423 — intervention group
Group type: COMPARATOR
Intervention: Higher L/A ratios in children with overweight/obesity compared to normal weight children
Number of subjects: 2258
Study 31845423 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper quartile L/A ratio in girls with overweight/obesity
Number of subjects: 2258
Study 31845423 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper quartile L/A ratio in boys with overweight/obesity
Number of subjects: 2258
Study 31845844 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion and perfusion MRI radiomics combined with next-generation sequencing (NGS)
Number of subjects: 0
Study 31845844 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 31845898 — intervention group
Group type: EXPERIMENTAL
Intervention: Outsourced remote management by an external remote monitoring center (ERMC)
Number of subjects: 153
Study 31845898 — intervention group
Group type: COMPARATOR
Intervention: Standard in-hospital management
Number of subjects: 153
Study 31846350 — intervention group
Group type: EXPERIMENTAL
Intervention: ROTEM parameters
Number of subjects: 0
Study 31846350 — intervention group
Group type: COMPARATOR
Intervention: Standard laboratory coagulation tests
Number of subjects: 0
Study 31846504 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with reduced capacity to work (RCW)
Number of subjects: 1183
Study 31846504 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean percentage reduced capacity to work (PRCW)
Number of subjects: 1183
Study 31846504 — intervention group
Group type: EXPERIMENTAL
Intervention: Total insurance costs for patients with RCW
Number of subjects: 1183
Study 31847007 — intervention group
Group type: EXPERIMENTAL
Intervention: Brexpiprazole
Number of subjects: 0
Study 31847007 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 31847794 — intervention group
Group type: EXPERIMENTAL
Intervention: History of stroke or transient ischemic attack
Number of subjects: 5617
Study 31847794 — intervention group
Group type: EXPERIMENTAL
Intervention: History of stroke
Number of subjects: 5617
Study 31847794 — intervention group
Group type: EXPERIMENTAL
Intervention: History of transient ischemic attack
Number of subjects: 5617
Study 31847861 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) treatment during adjuvant chemotherapy
Number of subjects: 310
Study 31847861 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy
Number of subjects: 310
Study 31847910 — intervention group
Group type: EXPERIMENTAL
Intervention: Balancing Everyday Life (BEL) intervention
Number of subjects: 133
Study 31847910 — intervention group
Group type: EXPERIMENTAL
Intervention: BEL intervention
Number of subjects: 133
Study 31848165 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal adiposity group receiving DFU management according to locally appropriate standards of care
Number of subjects: 300
Study 31848165 — intervention group
Group type: COMPARATOR
Intervention: High adiposity group receiving DFU management according to locally appropriate standards of care
Number of subjects: 300
Study 31848672 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day hepatic flow redistribution and Yttrium-90 radioembolization (90Y-RE)
Number of subjects: 22
Study 31848762 — intervention group
Group type: EXPERIMENTAL
Intervention: Submerged two-stage implants
Number of subjects: 20
Study 31848762 — intervention group
Group type: COMPARATOR
Intervention: Nonsubmerged one-stage implants
Number of subjects: 20
Study 31848762 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft tissue parameters (PI, PD, BOP, REC) for both groups
Number of subjects: 20
Study 31848762 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical keratinized tissue thickness (KTT)
Number of subjects: 20
Study 31848820 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative high protein β-hydroxy-β-methyl butyrate oral nutritional support (ONS)
Number of subjects: 35
Study 31848820 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative nutritional support targeting at least 1 g/kg/day protein and 20 kcal/kg/day caloric intake
Number of subjects: 35
Study 31848820 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative evaluation of PEM
Number of subjects: 35
Study 31848820 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between PEM at surgery and postoperative complications
Number of subjects: 35
Study 31848983 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 195
Study 31848983 — intervention group
Group type: COMPARATOR
Intervention: Basal-Bolus regimen
Number of subjects: 195
Study 31849164 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher heart rate in patients in sinus rhythm (SR)
Number of subjects: 13462
Study 31849164 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate per 10 bpm increase in patients in sinus rhythm (SR)
Number of subjects: 13462
Study 31849164 — intervention group
Group type: COMPARATOR
Intervention: Heart rate in patients in atrial fibrillation (AF)
Number of subjects: 13462
Study 31849202 — intervention group
Group type: EXPERIMENTAL
Intervention: Ra-223 (55 kBq/kg intravenously every 4 weeks) up to 6 cycles with endocrine therapy
Number of subjects: 36
Study 31849514 — intervention group
Group type: EXPERIMENTAL
Intervention: 10Hz transcranial alternating current stimulation (tACS) for 40 minutes
Number of subjects: 0
Study 31849514 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 31849532 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (CTCs elevated at baseline and cleared postbaseline)
Number of subjects: 126
Study 31849532 — intervention group
Group type: COMPARATOR
Intervention: Group 1 (elevated CTCs at baseline and postbaseline)
Number of subjects: 126
Study 31849532 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2
Number of subjects: 126
Study 31849532 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (no CTCs detected at baseline)
Number of subjects: 126
Study 31849532 — intervention group
Group type: COMPARATOR
Intervention: Group 1
Number of subjects: 126
Study 31849532 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3
Number of subjects: 126
Study 31849531 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab plus FOLFOX-4
Number of subjects: 0
Study 31849531 — intervention group
Group type: COMPARATOR
Intervention: FOLFOX-4 alone
Number of subjects: 0
Study 31849542 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg/week plus MTX (ETN+MTX)
Number of subjects: 423
Study 31849542 — intervention group
Group type: COMPARATOR
Intervention: Conventional DMARD plus MTX (DMARD+MTX)
Number of subjects: 423
Study 31849628 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation (tDCS) applied before the 6 min walk test (6MWT)
Number of subjects: 12
Study 31849628 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation (tDCS) applied during the 6 min walk test (6MWT)
Number of subjects: 12
Study 31849715 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress echocardiography derived tissue Doppler E/e' ratio
Number of subjects: 34
Study 31849715 — intervention group
Group type: COMPARATOR
Intervention: Resting echocardiographic parameters
Number of subjects: 34
Study 31850192 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (exact dosage and duration not specified)
Number of subjects: 0
Study 31850192 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 31850360 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g milk protein concentrate, 25 g maltodextrin, 7.75 g canola oil (treatment group)
Number of subjects: 17
Study 31850360 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric protein void drink (placebo group)
Number of subjects: 17
Study 31850360 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 17
Study 31850360 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 17
Study 31850847 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based module for electronic patient-reported outcomes (PROs) collection (APPEGE 2.0)
Number of subjects: 15
Study 31850853 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted Motivational Interviewing (AMI)
Number of subjects: 360
Study 31850853 — intervention group
Group type: EXPERIMENTAL
Intervention: Resident-run oral health campaigns
Number of subjects: 360
Study 31850853 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequence BA (Campaign followed by AMI)
Number of subjects: 360
Study 31850853 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequence AB (AMI followed by Campaign)
Number of subjects: 360
Study 31851315 — intervention group
Group type: EXPERIMENTAL
Intervention: DSMQ
Number of subjects: 11451
Study 31851315 — intervention group
Group type: EXPERIMENTAL
Intervention: Two 24HRs (mean)
Number of subjects: 11451
Study 31851315 — intervention group
Group type: COMPARATOR
Intervention: Single 24HR
Number of subjects: 11451
Study 31851315 — intervention group
Group type: EXPERIMENTAL
Intervention: DSMQ or at least one 24HR
Number of subjects: 11451
Study 31851315 — intervention group
Group type: EXPERIMENTAL
Intervention: 24HR day 1
Number of subjects: 11451
Study 31851315 — intervention group
Group type: COMPARATOR
Intervention: 24HR only
Number of subjects: 11451
Study 31851315 — intervention group
Group type: COMPARATOR
Intervention: Mean 24HR
Number of subjects: 11451
Study 31851518 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA-PKcs inhibitors with good PI3 kinase selectivity
Number of subjects: 0
Study 31851677 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary functional parameters
Number of subjects: 96
Study 31851677 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal functional parameters
Number of subjects: 96
Study 31851677 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral kidney arterial resistivity index (RI)
Number of subjects: 96
Study 31851677 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycaemia regulation
Number of subjects: 96
Study 31851677 — intervention group
Group type: EXPERIMENTAL
Intervention: Right kidney RI
Number of subjects: 96
Study 31851732 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-derived tumour models
Number of subjects: 10
Study 31851732 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific renal cancer tumouroids
Number of subjects: 10
Study 31851740 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous colorectal and liver resection
Number of subjects: 0
Study 31851762 — intervention group
Group type: EXPERIMENTAL
Intervention: Busulfan dosing based on fat free mass (FFM)
Number of subjects: 29
Study 31851762 — intervention group
Group type: COMPARATOR
Intervention: Conventional dosing based on total body mass
Number of subjects: 29
Study 31852086 — intervention group
Group type: EXPERIMENTAL
Intervention: Transforaminal epidural blocks
Number of subjects: 112
Study 31852086 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous epidural neuroplasty (PEN) without additional blocks
Number of subjects: 112
Study 31852086 — intervention group
Group type: COMPARATOR
Intervention: Runoff group (PEN with contrast runoff)
Number of subjects: 112
Study 31852086 — intervention group
Group type: COMPARATOR
Intervention: Non-runoff group (PEN without contrast runoff)
Number of subjects: 112
Study 31852421 — intervention group
Group type: EXPERIMENTAL
Intervention: HF with reduced ejection fraction (EF <40%)
Number of subjects: 6480
Study 31852421 — intervention group
Group type: EXPERIMENTAL
Intervention: HF with preserved ejection fraction (EF ≥50%)
Number of subjects: 6480
Study 31852421 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 6480
Study 31852421 — intervention group
Group type: EXPERIMENTAL
Intervention: Southeast Asian patients
Number of subjects: 6480
Study 31852421 — intervention group
Group type: EXPERIMENTAL
Intervention: South Asian patients
Number of subjects: 6480
Study 31852421 — intervention group
Group type: EXPERIMENTAL
Intervention: Northeast Asian patients
Number of subjects: 6480
Study 31852497 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermoplastic mask for head immobilization during stereotactic radiotherapy
Number of subjects: 5
Study 31852717 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratumoral delivery of IL12 through tavokinogene telseplasmid electroporation (tavo)
Number of subjects: 29
Study 31852810 — intervention group
Group type: EXPERIMENTAL
Intervention: TLC388 (Lipotecan) Hydrochloride, 40 mg/m², administered for a median of 2 treatment cycles (range, 0-6)
Number of subjects: 23
Study 31852847 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent prednisone administration
Number of subjects: 0
Study 31852847 — intervention group
Group type: COMPARATOR
Intervention: Chronic daily steroid use
Number of subjects: 0
Study 31853198 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-115 10 mg BID
Number of subjects: 118
Study 31853198 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-115 (various doses 0.5-40 mg/day)
Number of subjects: 118
Study 31853198 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-115 (10 mg BID)
Number of subjects: 118
Study 31853198 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-115 (in bioavailability substudy)
Number of subjects: 118
Study 31853198 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-115 (in cohort expansion)
Number of subjects: 118
Study 31853198 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-115 (in chronic lymphocytic leukemia/small lymphocytic lymphoma)
Number of subjects: 118
Study 31853265 — intervention group
Group type: EXPERIMENTAL
Intervention: Capmatinib 300 mg BID
Number of subjects: 38
Study 31853886 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovative Clinical Score (ICS) developed using data from 325 patients.
Number of subjects: 431
Study 31853886 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovative Clinical Score (ICS) validated using data from 106 patients.
Number of subjects: 431
Study 31853886 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration plots for the ICS.
Number of subjects: 431
Study 31853896 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-dimensional cranial ultrasonography for estimating absolute brain volumes (EABVs)
Number of subjects: 21
Study 31855161 — intervention group
Group type: EXPERIMENTAL
Intervention: Active lighting intervention
Number of subjects: 46
Study 31855161 — intervention group
Group type: COMPARATOR
Intervention: Control lighting intervention
Number of subjects: 46
Study 31855189 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 28
Study 31855189 — intervention group
Group type: COMPARATOR
Intervention: Health education group (control)
Number of subjects: 28
Study 31855231 — intervention group
Group type: EXPERIMENTAL
Intervention: mcfDNA-seq
Number of subjects: 47
Study 31855577 — intervention group
Group type: COMPARATOR
Intervention: Dynamic fluorine-19-enhanced MRI (19F MRI)
Number of subjects: 44
Study 31856021 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed transfer (n = 69)
Number of subjects: 308
Study 31856021 — intervention group
Group type: COMPARATOR
Intervention: Early transfer (n = 239)
Number of subjects: 308
Study 31856052 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified analgesia group (n=187)
Number of subjects: 361
Study 31856052 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (n=174)
Number of subjects: 361
Study 31856056 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound protocol (TRIP) for severity assessment of acute cor pulmonale (ACP) including tricuspid regurgitation velocity (T), right ventricular size (R), inferior vena cava diameter fluctuation (I), and pulmonary regurgitation velocity (P).
Number of subjects: 0
Study 31856739 — intervention group
Group type: EXPERIMENTAL
Intervention: New standard operating procedures (SOPs) for resuscitation room including early whole-body CT, damage control surgery, and goal-directed coagulation management.
Number of subjects: 512
Study 31856739 — intervention group
Group type: COMPARATOR
Intervention: Historic cohort (PreSOP)
Number of subjects: 512
Study 31856739 — intervention group
Group type: EXPERIMENTAL
Intervention: New SOPs
Number of subjects: 512
Study 31856786 — intervention group
Group type: EXPERIMENTAL
Intervention: King's Brief Interstitial Lung Disease questionnaire (K-BILD)
Number of subjects: 150
Study 31856786 — intervention group
Group type: EXPERIMENTAL
Intervention: K-BILD
Number of subjects: 150
Study 31856860 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiogenic shock (CS)
Number of subjects: 37
Study 31856860 — intervention group
Group type: EXPERIMENTAL
Intervention: Septic shock (SS)
Number of subjects: 37
Study 31856860 — intervention group
Group type: COMPARATOR
Intervention: Septic controls (SC)
Number of subjects: 37
Study 31857311 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prescription (yes/no)
Number of subjects: 4831
Study 31857311 — intervention group
Group type: EXPERIMENTAL
Intervention: Female GP sex
Number of subjects: 4831
Study 31857311 — intervention group
Group type: EXPERIMENTAL
Intervention: GP age (≥60 years)
Number of subjects: 4831
Study 31857311 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient age (≥65 years)
Number of subjects: 4831
Study 31857311 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of signs/symptoms (≥4)
Number of subjects: 4831
Study 31857311 — intervention group
Group type: EXPERIMENTAL
Intervention: Fever
Number of subjects: 4831
Study 31857311 — intervention group
Group type: EXPERIMENTAL
Intervention: Productive cough
Number of subjects: 4831
Study 31857311 — intervention group
Group type: EXPERIMENTAL
Intervention: Otalgia
Number of subjects: 4831
Study 31857311 — intervention group
Group type: EXPERIMENTAL
Intervention: Tender cervical nodes
Number of subjects: 4831
Study 31857311 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular clients
Number of subjects: 4831
Study 31857311 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic requests
Number of subjects: 4831
Study 31857311 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 4831
Study 31857311 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-productive cough
Number of subjects: 4831
Study 31857311 — intervention group
Group type: EXPERIMENTAL
Intervention: Sore throat
Number of subjects: 4831
Study 31857311 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhinorrhoea
Number of subjects: 4831
Study 31857311 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyspnoea
Number of subjects: 4831
Study 31857726 — intervention group
Group type: EXPERIMENTAL
Intervention: Vismodegib added to gemcitabine and nab-paclitaxel starting on the second cycle
Number of subjects: 71
Study 31857726 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine and nab-paclitaxel (historical control)
Number of subjects: 71
Study 31858293 — intervention group
Group type: EXPERIMENTAL
Intervention: PET/CT imaging
Number of subjects: 8
Study 31858327 — intervention group
Group type: EXPERIMENTAL
Intervention: Dacomitinib 45 mg every 12 hours for six doses in a 7-day lead-in cycle (cycle 0) followed by 60 mg every 12 hours for six doses in a 14-day cycle (cycle 1)
Number of subjects: 32
Study 31858327 — intervention group
Group type: EXPERIMENTAL
Intervention: Dacomitinib
Number of subjects: 32
Study 31858403 — intervention group
Group type: EXPERIMENTAL
Intervention: Point shear wave elastography (pSWE)
Number of subjects: 251
Study 31858837 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-Based Exercise Prehabilitation
Number of subjects: 0
Study 31858880 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 31859468 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypodium leucotomos extract (PLE) 480 mg daily for 28 days
Number of subjects: 22
Study 31859468 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypodium leucotomos extract (PLE)
Number of subjects: 22
Study 31859686 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash transfer delivered over 18 months in addition to other HIV interventions
Number of subjects: 30
Study 31859686 — intervention group
Group type: COMPARATOR
Intervention: Other HIV interventions without cash transfer
Number of subjects: 30
Study 31859688 — intervention group
Group type: EXPERIMENTAL
Intervention: Rent subsidies for 24 months
Number of subjects: 24
Study 31859688 — intervention group
Group type: EXPERIMENTAL
Intervention: Rent subsidies for 24 months + adult mentoring
Number of subjects: 24
Study 31859705 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning symptoms
Number of subjects: 593
Study 31859705 — intervention group
Group type: EXPERIMENTAL
Intervention: Nighttime symptoms
Number of subjects: 593
Study 31859705 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime symptoms
Number of subjects: 593
Study 31859705 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe symptoms
Number of subjects: 593
Study 31859705 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 593
Study 31860140 — intervention group
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin (BV) 1.8 mg/kg with MEC (mitoxantrone, etoposide, cytarabine)
Number of subjects: 22
Study 31860140 — intervention group
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin (BV) with MEC
Number of subjects: 22
Study 31860525 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG-PET/CT with CT-based segmentation methodology
Number of subjects: 71
Study 31861009 — intervention group
Group type: EXPERIMENTAL
Intervention: Omadacycline
Number of subjects: 368